Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of 1672.HK is 25 and suggests 64% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell